A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Parecoxib After Intravenous Bolus of Parecoxib in Healthy Volunteers Under Fasting Conditions
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT06600282
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06161792
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taipei, Taiwan
🇨🇳National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳Taichung Veterans General Hospital, Taichung, Taiwan
Evaluate Bioequivalence of Burotam (1/1 g/Vial)
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT05654090
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Evaluate Bioequivalence of Micafungin (50mg/Vial)
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT05496725
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Folds.
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2021-09-10
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05040594
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT04671563
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT04585412
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Evaluate Bioequivalence of Voriconazole(200mg/Vial) .
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2020-09-17
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT04552353
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Pharmacokinetics of Nalbuphine Injection
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT03826316
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
Pharmacokinetics of Two Formulation of Pregabalin
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2019-01-28
- Lead Sponsor
- Yung Shin Pharm. Ind. Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT03712475
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
© Copyright 2024. All Rights Reserved by MedPath